Please assess the completion status of the following clinical trial:

Trial Title: Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Community dwelling patients 65 years of age or older diagnosed with Type 2 Diabetes not controlled with diet and exercise~* Patients must have a HbA1c of 7-10% off medication, or as a result of a protocol wash-out from oral anti-hyperglycemic agents by the qualifying visit~Exclusion Criteria:~* Patients with type 1 diabetes~* History of ketoacidosis or requires insulin use~* Alanine aminotransferase / aspartate aminotransferase \> 2.5 X ULN, triglycerides \> 600 mg/dL, creatinine clearance \< 35 mL/min~* Fasting plasma glucose consistently \> 260 mg/dL~* Poorly controlled hypertension

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): sitagliptin
- 2 (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).